University of Nebraska Medical Center

Julie M. Vose, MD, MBA

Division Chief
Neumann M. and Mildred E. Harris Professor
Division of Hematology & Oncology
Non-Hodgkin Lymphoma, Hodgkin Disease, Multiple Myeloma, Chronic Lymphocytic Leukemia

Julie M .Vose, MD

Dr. Vose is an oncology and hematology physician and the Chief of the Division of Oncology and Hematology at the University of Nebraska Medical Center/Nebraska Medicine. Her personal research involves treating patients with non-Hodgkin lymphoma, Hodgkin lymphoma, and chronic lymphocytic leukemia. Her clinical areas of focus include chemotherapy, immunotherapy, cellular therapy, and pathway directed agents for treatment and clinical trial research.

Dr. Vose has been involved in oncology and hematology for more than 30 years and she had the honor of serving as the President of the American Society of Clinical Oncology (ASCO) in 2016. She has published more than 400 manuscripts on the treatment of patients with lymphoma or related entities.


  • Medical School: UNMC College of Medicine, 1984
  • Residency: Internal Medicine, UNMC College of Medicine, 1987
  • Residency: Internal Medicine, UNMC College of Medicine, 1988
  • Fellowship: Hematology/Oncology, UNMC College of Medicine, 1990
  • MBA: University of Colorado, 2011
Research Interests

Dr. Vose's research interests include:

  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Stem Cell Transplantation
  • CAR-T Cell Transplantation